Table 1 Histological evaluation of tumour infiltrating lymphocytes in the melanocytic skin lesions .
| Material | Total TIL | Positioning of TIL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parenchyma | Stroma | Base | Perivascular | Epidermis | SIL | |||||||||
| Normal skin | 3.9 (0.6) | – | 3.9 (0.6) | – | – | – | 3.9 (0.6) | |||||||
| BN | 26.8 (1.3) | 28.2 (2.9) | 35 (1.9) | 50 (1.2) | 14.6 (3.3) | 5.8 (3.1) | 33.2 (1.4) | |||||||
| DN | 39 (3.6) | 40.8 (7.3) | 53.3 (2.2) | 71 (1.8) | 24.6 (7.8) | 5.8 (5.8) | 49.5 (3.1) | |||||||
| CMM* | 81.1 (2.5) | 78.4 (3.5) | 83.3 (3.5) | 90.8 (1.5) | 70.8 (3.9) | – | 82.4 (2.4) | |||||||
| RGP‐CMM | 67.4 (4.3) | 64.6 (5.9) | 65.2 (8.1) | 80.2 (1.5) | 52.6 (6.3) | – | 63.4 (4.3) | |||||||
| VGP‐CMM | 87.9 (2) | 85.3 (3.8) | 92.4 (1.5) | 96 (1.1) | 80 (3.9) | 78 (1.2) | 87.9 (2) | |||||||
| Met‐MM | 39.6(3.7) | 39.6 (3.7) | – | – | – | – | – | |||||||
Data are mean (SEM). BN, benign naevi; MDN, dysplastic naevi; MM*; cutaneous malignant melanoma referred to total count of RGP‐CMM and VGP‐CMM; RGP‐CMM, radial growth phase cutaneous malignant melanoma; VGP‐CMM, vertical growth phase cutaneous malignant melanoma; Met‐MM, metastatic malignant melanoma.